Follow the 비스토스 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 비스토스 has logged 24 reports. Market capitalisation: €12.8bn. The latest transaction was disclosed on 6 April 2026 (Purchase). Among the most active insiders: 이후정. Every trade is openly available.
24
Insider Decl.
n/a
Thresholds
n/a
4 ops.
Buy Volume
n/a
12 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,525 of 29,062 companies
20.5
score / 100
Value
15
Quality
26
FCF yld-18%
Earn yld-5.4%
EV/EBITDA·
ROE·
Gross mgn25%
Net mgn-4.1%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
비스토스 es una empresa de salud y farmacéutica que cotiza en el mercado XKRX. Se centra en el desarrollo de soluciones innovadoras para mejorar la atención médica.